Melissa brings decades of experience in the vaccine industry, spanning the public and private sectors. She currently works as a consultant for global health clients.
Melissa has had a twenty-year career in global vaccines spanning the public and private sectors. She is currently consulting independently and as a Senior Advisor with MMGH Consulting with clients including Gavi, the Vaccine Alliance, the Bill and Melinda Gates Foundation, PATH, the World Health Organization, The Wellcome Trust, the Coalition for Epidemic Preparedness and Innovations and vaccine manufacturers.
From 2013 until late 2017, Melissa led the design and implementation of Gavi’s market shaping efforts. In that capacity she was accountable for ensuring adequate and timely supply of vaccines at affordable prices for Gavi, for setting long-term access strategies for sixteen vaccines and for leading Alliance relationships with the vaccine industry. During this time she was engaged in evaluating or negotiating six bespoke agreements with industry, resulting in savings of over $500 million.
Prior to Gavi, Ms. Malhame had nearly 20 years of experience in the vaccine industry with both a large multi-national manufacturer and an emerging vaccine company. Her industry experience includes leading late stage vaccine development, business and commercial development, marketing and sales. She served as a member of the Center for Global Development working group on the Future of Global Healthcare Procurement and as an advisor to Jansen Global Public Health.
Ms. Malhame has published on the experiences and results of market shaping and pricing transparency. She received a Masters in Business Administration from the Johnson Graduate School of Management at Cornell University.